Enhancing and initiating phage-based therapies

Drug development has typically been a primary foundation of strategy for systematic, long-range management of pathogenic cells. However, drug development is limited in speed and flexibility when response is needed to changes in pathogenic cells, especially changes that produce drug-resistance. The h...

Descripción completa

Detalles Bibliográficos
Autores principales: Serwer, Philip, Wright, Elena T, Chang, Juan T, Liu, Xiangan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Evergreen Meeting
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588221/
https://www.ncbi.nlm.nih.gov/pubmed/26713220
http://dx.doi.org/10.4161/21597073.2014.961869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588221/
https://www.ncbi.nlm.nih.gov/pubmed/26713220
http://dx.doi.org/10.4161/21597073.2014.961869

Ejemplares similares